Antipsychotic Agents: all 1,814 studies that test it
Page 1 of 19. Open to participants first (97), then studies with results posted, then the rest; newest registration first within each.
- Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic SurgeryNot yet recruitingNCT07891312Not applicable
- The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.Not yet recruitingNCT07810738Phase 2
- Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar DisorderNot yet recruitingNCT07806227Phase 4
- Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyNot yet recruitingNCT07781293Phase 3
- Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency DepartmentNot yet recruitingNCT07726069Early Phase 1
- A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With SchizophreniaNot yet recruitingNCT07722728Phase 2/3
- Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in SchizophreniaNot yet recruitingNCT07715253Phase 1
- Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)Not yet recruitingNCT07714213Phase 2
- Risperidone vs Cariprazine in Acute ManiaNot yet recruitingNCT07665073Phase 4
- Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative ChemotherapyRecruitingNCT07633236Phase 3
- Application of Multimodal Intervention in the Prevention of Postoperative Nausea and Vomiting After Gynecological Laparoscopic SurgeryNot yet recruitingNCT07631910Not applicable
- The Impact of Cobenfy Maintenance on Cocaine's EffectsRecruitingNCT07624227Phase 1/2
- Psilocybin Efficacy With or Without Pimavanserin PretreatmentRecruitingNCT07610135Phase 1/2
- GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric CancerNot yet recruitingNCT07581405Phase 2
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruitingNCT07565428Phase 3
- Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.Not yet recruitingNCT07547384Not applicable
- A Bioequivalence Study of PP3M in Patients With SchizophreniaRecruitingNCT07493551Not applicable
- Cerebellum-based Imaging Neural Markers for Antipsychotic ResponseRecruitingNCT07483294Phase 4
- An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HECRecruitingNCT07482891Phase 4
- A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and PalonosetronNot yet recruitingNCT07442890Not applicable
- Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing RegimenRecruitingNCT07413809Phase 3
- Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical SettingsNot yet recruitingNCT07348172Early Phase 1
- RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)RecruitingNCT07266545Phase 4
- Dopamine and Sensorimotor Function in StutteringRecruitingNCT07215884Phase 1
- Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and VomitingRecruitingNCT07208305Phase 3
- Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral CariprazineRecruitingNCT07185815Phase 1/2
- Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh StudyNot yet recruitingNCT07153835Phase 4
- Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?RecruitingNCT07109245Phase 4
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionRecruitingNCT07090161Phase 2
- A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's DiseaseNot yet recruitingNCT07085195Early Phase 1
- Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in SchizophreniaNot yet recruitingNCT07075237Phase 4
- Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic ChemotherapyNot yet recruitingNCT07035821Phase 3
- Investigating the Neuropsychological Effects of 5-HT2a AntagonismRecruitingNCT07022366Not applicable
- Assessment of Drug Liking In Peri-procedural Clinical SettingsEnrolling by invitationNCT07015528Early Phase 1
- A Clinical Trial of Adjunctive Thyroxine for Avolition in SchizophreniaNot yet recruitingNCT07011953Early Phase 1
- Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression（SMART-I)Not yet recruitingNCT07011693Phase 4
- Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRecruitingNCT06995508Phase 2
- Biomarkers to Enhance Early Schizophrenia TreatmentRecruitingNCT06969755Phase 4
- Randomized Withdrawal Study in Patients With SchizophreniaRecruitingNCT06961968Phase 3
- Olanzapine Versus Placebo for Moderately Emetogenic ChemotherapyRecruitingNCT06850454Phase 3
- Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderRecruitingNCT06830044Phase 3
- Subjective Experience Following PsilocybinRecruitingNCT06768944Phase 2
- Exercise and Olanzapine-samidorphanRecruitingNCT06740890Phase 4
- Study on Hibernation-like Therapy Based on Mechanical ThrombectomyRecruitingNCT06663631Phase 1
- Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive DisorderRecruitingNCT06592833Phase 2
- Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose MelphalanRecruitingNCT06588413Phase 3
- Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLCRecruitingNCT06554613Phase 2
- Quetiapine Versus Trazadone in Women With Postpartum DepressionNot yet recruitingNCT06546358Early Phase 1
- Olanzapine for Cancer Related Anorexia-cachexia SyndromeRecruitingNCT06517199Phase 3
- Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)RecruitingNCT06512220Phase 2
- Nutrition Impact on Immunotherapy of CancerRecruitingNCT06500234Phase 3
- Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.RecruitingNCT06482554Phase 3
- Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency DepartmentRecruitingNCT06395428Phase 4
- Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung CancerRecruitingNCT06338683Phase 3
- Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)RecruitingNCT06333990Phase 3
- The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBMNot yet recruitingNCT06218524Phase 2
- NRX-101 for Complicated Urinary Tract Infection (UTI) Including PyelonephritisNot yet recruitingNCT06128213Phase 2
- Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid InsomniaRecruitingNCT06062953Phase 2/3
- Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology AnalysisNot yet recruitingNCT06060886Phase 4
- Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum DisorderRecruitingNCT05999240Phase 2
- The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.RecruitingNCT05958875Phase 4
- Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive DisorderNot yet recruitingNCT05933538Phase 4
- Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)RecruitingNCT05913947Phase 4
- The Danish Out-of-Hospital Cardiac Arrest StudyRecruitingNCT05895838Phase 3
- Pimavanserin and Aggression and Social Cognition.RecruitingNCT05895513Phase 2
- Effect of Adding Lamotrigine to Sodium Valproate in Childhood Epilepsy: Clinicolabratory StudyNot yet recruitingNCT05881928Phase 4
- EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIALNot yet recruitingNCT05868720Not applicable
- Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)RecruitingNCT05814640Phase 1/2
- Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCTNot yet recruitingNCT05766540Phase 4
- Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKERecruitingNCT05762146Phase 2
- The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal EpilepsyEnrolling by invitationNCT05748236Phase 4
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerRecruitingNCT05705492Phase 2
- Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsRecruitingNCT05648591Phase 4
- Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac SurgeryRecruitingNCT05635227Not applicable
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureRecruitingNCT05603104Phase 3
- Comparing Antipsychotic Medications in LBD Over TimeRecruitingNCT05590637Phase 4
- Aripiprazole in Body Focused Repetitive BehaviorsNot yet recruitingNCT05545891Phase 2
- Chinese Longitudinal and Systematic Study of Bioplar DisorderRecruitingNCT05480150Not applicable
- Pimavanserin for Insomnia in Veterans With PTSDRecruitingNCT05441280Phase 2
- Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing StrategyRecruitingNCT05431595Phase 2/3
- Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on AnhedoniaRecruitingNCT05389046Not applicable
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative DiseasesRecruitingNCT05357612Phase 4
- Biomarkers in Clozapine-responding SchizophreniaRecruitingNCT05316883Phase 4
- Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical TrialRecruitingNCT05208190Phase 4
- Safety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaRecruitingNCT05184335Phase 3
- Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage CancerEnrolling by invitationNCT05170919Phase 2
- Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsEnrolling by invitationNCT04987229Phase 3
- Modification of Epilepsy Screen Questionnaire and Treatment Feasibility EvaluationNot yet recruitingNCT04939675Not applicable
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.RecruitingNCT04777357Phase 3
- Improving Sleep After TKA Using Mirtazapine and QuetiapineNot yet recruitingNCT04728581Not applicable
- CLOZAPINE Response in Biotype-1RecruitingNCT04580134Phase 4
- "Extended" (Alternate Day) Antipsychotic DosingRecruitingNCT04478838Phase 4
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisRecruitingNCT04373317Phase 4
- Asian Diabetes Outcomes Prevention TrialRecruitingNCT04286399Phase 4
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaRecruitingNCT03817502Phase 3
- Switching From Twice-Daily to Once-Daily Clozapine Dosing in SchizophreniaRecruitingNCT02639702Phase 4
- The Psychiatric and Cognitive Phenotypes in Velocardiofacial SyndromeRecruitingNCT00768820Phase 4
- A Trial to Assess a Wearable Patch's Functioning to Detect Medication IngestionCompletedNCT06372210Not applicableResults posted
- Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderCompletedNCT06319170Phase 1Results posted
- Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaCompletedNCT06253546Phase 1Results posted